The trademark application DURYSTRA was filed by Allergan, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on October 5, 2021, and it was registered by office on January 12, 2022 without any oppositions.
The application was filed in English (French was selected as the second language).